Gilead Wins Major HIV Liability Ruling as Lilly Expands Obesity Drug Access
By Ed Silverman · STAT News · 2026-08-04

STAT News reports that Gilead Sciences successfully defended its drug development timeline before the California Supreme Court, avoiding liability for the pace of its HIV medication rollouts. Simultaneously, Eli Lilly is formalizing a process for patients to request its experimen
STAT News reports that Gilead Sciences successfully defended its drug development timeline before the California Supreme Court, avoiding liability for the pace of its HIV medication rollouts. Simultaneously, Eli Lilly is formalizing a process for patients to request its experimen